Skip to content

Sartorius Stedim Biotech SA Price, Chart & Factor Exposure

Free Data & Analytics Access

Next earnings: Tue, Feb 23, 2027, after the market closes · estimates and history

Sartorius Stedim Biotech SA · E.DIM.PA · France
Use symbol E.DIM.PA in our API & Excel add-in to retrieve this data ↓
224.20
(+0.00%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 100%
Trend 100%
Bubble Risk LOW
Realised Volatility (20D) 33.93%

Sartorius Stedim Biotech SA Forecast

Sartorius Stedim Biotech SA short-term momentum is strongly positive (up over 4 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (8 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 33.9% a year, a typical one-standard-deviation range is 213.48–234.92 over a week, 202.24–246.16 over a month and 148.12–300.28 over a year. (Signals as of 5 Nov 2026.)

Sartorius Stedim Biotech SA Price Chart

MacroFinance.ai

Sartorius Stedim Biotech SA Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Sartorius Stedim Biotech SA
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Sartorius Stedim Biotech SA
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Sartorius Stedim Biotech SA
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
Sartorius Stedim Biotech SA
P/E
67.35x
Mid-range vs own history
QoQ +4.7%
YoY −3.9%
now 67.347555.43 low78.64 high
ⓘP/E As of 22 Nov 2026.See Sartorius Stedim Biotech SA returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
Sartorius Stedim Biotech SA
P/S
7.13x
Mid-range vs own history
QoQ +13.7%
YoY +13.6%
now 7.12525.08 low7.18 high
ⓘP/S As of 22 Nov 2026.See Sartorius Stedim Biotech SA returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
Sartorius Stedim Biotech SA
P/B
4.98x
Mid-range vs own history
QoQ +12.1%
YoY +8.8%
now 4.98263.69 low5.14 high
ⓘP/B As of 22 Nov 2026.See Sartorius Stedim Biotech SA returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
Sartorius Stedim Biotech SA
EV/EBITDA
26.59x
Mid-range vs own history
QoQ +12.1%
YoY +3.5%
now 26.592920.35 low28.49 high
ⓘEV/EBITDA As of 22 Nov 2026.See Sartorius Stedim Biotech SA returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
Sartorius Stedim Biotech SA
EV/Sales
7.82x
Mid-range vs own history
QoQ +11.8%
YoY +11.1%
now 7.82375.78 low7.87 high
ⓘEV/Sales As of 22 Nov 2026.See Sartorius Stedim Biotech SA returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
Sartorius Stedim Biotech SA
FCF Yield
1.2%
Mid-range vs own history
QoQ +5.4%
YoY −2.3%
now 1.23550.74 low1.4 high
ⓘFCF Yield As of 22 Nov 2026.See Sartorius Stedim Biotech SA returns when FCF Yield looked like now →Opens Return analysis with the filter FCF Yield within ±5% of today
Sartorius Stedim Biotech SA
Earnings Yield
1.5%
Mid-range vs own history
QoQ −4.5%
YoY +4.0%
now 1.48481.27 low1.8 high
ⓘEarnings Yield As of 22 Nov 2026.See Sartorius Stedim Biotech SA returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
Sartorius Stedim Biotech SA
Market Cap
$21.8B
Mid-range vs own history
QoQ +15.9%
YoY +18.0%
now 21813.852915,169 low21,970 high
ⓘMarket Cap As of 22 Nov 2026.See Sartorius Stedim Biotech SA returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
Sartorius Stedim Biotech SA
Net Debt
$2.1B
Mid-range vs own history
QoQ −2.7%
YoY −5.6%
now 2138.42,093 low2,324 high
ⓘNet Debt As of 22 Nov 2026.See Sartorius Stedim Biotech SA returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
Sartorius Stedim Biotech SA
Net Debt / EBITDA
2.37x
Mid-range vs own history
QoQ −4.3%
YoY −15.3%
now 2.37422.37 low2.8 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See Sartorius Stedim Biotech SA returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
Sartorius Stedim Biotech SA
Current Ratio
1.22x
Mid-range vs own history
QoQ +5.1%
YoY +15.7%
now 1.21911.02 low1.22 high
ⓘCurrent Ratio As of 22 Nov 2026.See Sartorius Stedim Biotech SA returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
Sartorius Stedim Biotech SA
Quick Ratio
0.57x
Mid-range vs own history
QoQ +3.3%
YoY +12.6%
now 0.56560.5 low0.58 high
ⓘQuick Ratio As of 22 Nov 2026.See Sartorius Stedim Biotech SA returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
Sartorius Stedim Biotech SA
Interest Coverage
3.66x
Mid-range vs own history
QoQ +16.3%
YoY +16.3%
now 3.65922.89 low3.66 high
ⓘInterest Coverage As of 22 Nov 2026.See Sartorius Stedim Biotech SA returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
Sartorius Stedim Biotech SA
Debt / Equity
0.53x
Mid-range vs own history
QoQ −6.9%
YoY −16.9%
now 0.52770.53 low0.67 high
ⓘDebt / Equity As of 22 Nov 2026.See Sartorius Stedim Biotech SA returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
Sartorius Stedim Biotech SA
Piotroski F-Score
8
Strong vs own history
QoQ 0.0%
YoY 0.0%
now 87 low8 high
ⓘPiotroski F-Score As of 22 Nov 2026.See Sartorius Stedim Biotech SA returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
Sartorius Stedim Biotech SA
Altman Z-Score
4.75
Mid-range vs own history
QoQ +12.8%
YoY +19.9%
now 4.75293.29 low4.78 high
ⓘAltman Z-Score As of 22 Nov 2026.See Sartorius Stedim Biotech SA returns when Altman Z-Score looked like now →Opens Return analysis with the filter Altman Z-Score within ±5% of today
  18 members-only factors: Revenue Growth, Revenue CAGR 3Y, Earnings Growth, EBITDA Growth and moreSign up
Accounting Red Flags
  17 members-only factors: Sloan Accruals, Cash-Earnings Gap, Beneish M-Score, Days Sales in Receivables Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for Sartorius Stedim Biotech SA, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Sartorius Stedim Biotech SA fundamentals: income statement, balance sheet & cash flow

Sartorius Stedim Biotech SA reported revenue of €2.97bn and net income of €265.6m in FY2025, the year ended 31 December 2025 — revenue up 6.7% and net income up 51.7% on the prior year. Free cash flow was €145.4m. These figures are as reported in the filings, not restated: 21 fiscal years and 59 quarters of history, back to December 2005.

Revenue (FY2025)
€2.97bn
+6.7%
Net income
€265.6m
+51.7%
Gross margin
45.33%
Free cash flow
€145.4m
-69.4%
Net debt
€2.17bn
Sartorius Stedim Biotech SA income statement, annual, as reported · EUR millions unless stated
EUR millionsFY2025FY2024FY2023FY2022FY2021
Period end31 Dec 202531 Dec 202431 Dec 202331 Dec 202231 Dec 2021
Revenue2,967.52,780.02,775.53,492.72,887.0
Cost of revenue1,622.21,573.31,542.01,658.21,334.0
Gross profit1,345.31,206.71,233.51,817.41,553.0
Research & development132.6144.1129.5132.4110.5
Selling, general & admin.661.3692.0619.5—529.8
Operating income549.0370.6484.51,101.2912.7
EBITDA867.1670.5755.71,330.7812.0
Interest expense152.7158.9121.141.023.7
Pre-tax income373.2219.2401.11,130.4646.7
Income tax107.340.789.0250.5232.4
Net income265.6175.1309.7876.1414.4

Download Sartorius Stedim Biotech SA fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.DIM.PA&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 21 fiscal years and 59 quarters, the filing vintages behind each number and API access.
Create free account

Figures in EUR, statements as filed. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic.

Research on Sartorius Stedim Biotech SA

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Sartorius Stedim Biotech SA Trading Strategies

9 backtested tactical asset allocation strategies hold VGK (European market), the closest tradable exposure to Sartorius Stedim Biotech SA; 1 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

Explore all strategies →

Statistical Distribution of Returns

Plus

How Sartorius Stedim Biotech SA’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Sartorius Stedim Biotech SA behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Sartorius Stedim Biotech SA (France)

Sartorius Stedim Biotech SA is a listed security in France. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

More on Sartorius Stedim Biotech SA

Frequently asked questions

What is Sartorius Stedim Biotech SA?
Sartorius Stedim Biotech SA is a listed security in France. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Sartorius Stedim Biotech SA price?
The latest close is 224.2 (5 Nov 2026), +0.00% on the day. The price at the top of the page refreshes during the trading day.
Is Sartorius Stedim Biotech SA in an uptrend?
As of 5 Nov 2026, short-term momentum is strongly positive (4 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly positive (8 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Sartorius Stedim Biotech SA?
20-day realised volatility is 33.9% a year (5 Nov 2026), which implies a typical one-standard-deviation move of about 9.8% over a month and 4.8% over a week.
What factors affect Sartorius Stedim Biotech SA?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Sartorius Stedim Biotech SA, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Sartorius Stedim Biotech SA?
9 backtested tactical asset allocation strategies trade Sartorius Stedim Biotech SA through VGK; 1 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Sartorius Stedim Biotech SA returns analysed?
The Statistical Distribution of Returns section shows the distribution of Sartorius Stedim Biotech SA daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Sartorius Stedim Biotech SA historical data?
In the Free historical data section of this page: the last 10 years of Sartorius Stedim Biotech SA daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Sartorius Stedim Biotech SA historical data (last 10 years)

Browse or instantly download the last 10 years of Sartorius Stedim Biotech SA daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.DIM.PA&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-20220.6
2026-11-19228.6
2026-11-18226.8
2026-11-17224.2
2026-11-16225.2
2026-11-13223.2
2026-11-12222.8
2026-11-11226.8
2026-11-10223.4
2026-11-09226.2
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides fluid management services; biolayer interferometry instruments; microbiology testing, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; screening instruments; biomolecule analysis tools; batch liquid chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; water purification systems; and weighing products. In addition, the company offers data analytics software; process automation platform and software; and transfection reagents and plasmid DNA solutions. The company has a collaboration with Bio Usawa Biotechnology, Ltd. focusing on developing and manufacturing monoclonal antibodies in Sub-Saharan Africa to tackle oncology, diabetes-induced eye diseases, infectious diseases, and autoimmune conditions. It serves manufacturers of medications, vaccines, food, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.